Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Abstract Full Text (PDF, 135K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Carter, L. L. Articles by Murphy, K. M. Search for Related Content PubMed PubMed Citation Articles by Carter, L. L. Articles by Murphy, K. M. Social Bookmarking                            What's this?

Brief Definitive Reports

Lineage-specific Requirement for Signal Transducer and Activator of Transcription (Stat)4 in Interferon Production from CD4⁺ Versus CD8⁺ T Cells

From the Department of Pathology and Center for Immunology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110

	Abstract

Top Abstract Materials and Methods Results Discussion References

 
CD4⁺ and CD8⁺ T cells exhibit important differences in their major effector functions. CD8⁺ T cells provide protection against pathogens through cytolytic activity, whereas CD4⁺ T cells exert important regulatory activity through production of cytokines. However, both lineages can produce interferon (IFN)-, which can contribute to protective immunity. Here we show that CD4⁺ and CD8⁺ T cells differ in their regulation of IFN- production. Both lineages require signal transducer and activator of transcription (Stat)4 activation for IFN- induced by interleukin (IL)-12/IL-18 signaling, but only CD4⁺ T cells require Stat4 for IFN- induction via the TCR pathway. In response to antigen, CD8⁺ T cells can produce IFN- independently of IL-12, whereas CD4⁺ T cells require IL-12 and Stat4 activation. Thus, there is a lineage-specific requirement for Stat4 activation in antigen-induced IFN- production based on differences in TCR signaling between CD4⁺ and CD8⁺ T cells.

Key Words: Stat4 • interferon • T lymphocytes • interleukin 12 • interleukin 18

Interferon (IFN)- enhances defense against bacterial and viral pathogens (1) and is produced by both innate and adaptive immune cells, including NK cells, CD8⁺ T cells, and CD4⁺ T cells. NK cells are an important source of IFN- in early infection, and can secrete IFN- upon initial activation (2). In contrast, CD4⁺ cells produce little IFN- on primary activation and require cytokine-dependent differentiation to acquire this capacity (3, 4). Further, CD4⁺ T cells exhibit a developmental dichotomy diverging to either an IFN-–producing (Th1) or IL-4–producing (Th2) phenotype (5, 6). A similar paradigm was recently extended to CD8⁺ T cells, where Tc1 and Tc2 subsets develop in response to conditions that induce Th1 and Th2 subsets (7–10). However, unlike Th2 cells, Tc2 cells retain the capacity for IFN- production, although reduced compared with Tc1 cells, and produce quantitatively less IL-4 relative to their CD4 counterpart (7).

For CD4⁺ T cells, Th1/Th2 polarization involves IL-12 and IL-4 signaling via the JAK-STAT Janus kinases/signal transducer and activator of transcription) pathway (11–15). The role of IL-12 in Th1 development was established using both IL-12– and Stat4-deficient mice (12, 13, 16). IL-12 p40-deficient mice had impaired NK responses and lower IFN- production from CD4⁺ T cells (16), but IFN- secretion by LAK cells and generation of allo-specific CTL were unimpeded. These studies suggested IL-12–independent pathways in NK cells and CTLs. Stat4-deficient mice exhibit reduced but not absent IFN- production (12, 13), but the source was not apparent, since these studies used unseparated splenocytes and polyclonal activation. In sum, these studies suggest not all cell types are entirely IL-12 and Stat4 dependent for IFN- production.

The TCR pathway has been considered the only physiologic stimuli for IFN- induction in CD4⁺ T cells. However, IL-12 and IL-18 were shown to induce IFN- production in Th1 cells by a TCR-independent mechanism (17). The pathways activated by TCR and IL-12/IL-18 treatment are differentially sensitive to Cyclosporin A inhibition and appear to induce IFN- transcription through activation of distinct sets of factors (18). Thus the requirements for Stat4 and IL-12 in IFN- production may depend on the activating stimulus as well as the cell type.

In this study, we directly compared the CD4⁺ and CD8⁺ T cells for IL-12 and Stat4 requirements in IFN- induction through the TCR or IL-12/IL-18 pathways. We find that CD4⁺ and CD8⁺ T cells exhibit lineage-specific differences in requiring Stat4-activation for IFN- production. Specifically, both CD4⁺ and CD8⁺ T cells require Stat4 in IL-12/IL-18 induction of IFN-, but only CD4⁺ T cells require Stat4 for TCR induced IFN- production.

	Materials and Methods

Top Abstract Materials and Methods Results Discussion References

 
Animals.
Stat4-deficient DO11.10 TCR-transgenic mice have been described previously (12, 19). 2C TCR transgenic mice (20) were obtained from Dr. T. Hansen (Washington University, St. Louis, MO).

Cytokines, Antibodies, and Other Reagents.
Recombinant human IL-2, IL-4, IL-12, and KJ1-26 (21) were used as previously described (19). Recombinant murine IL-18 (Research Diagnostics Inc.) was used at 50 ng/ml. Anti–IL-12 (TOSH) (22) and anti– IFN- (H22) (from Dr. R.D. Schreiber, Washington University, St. Louis, MO) were used at 10 µg/ml. Anti-CD3 (2C11) (from Dr. A. Shaw, Washington University, St. Louis, MO) was coated at 10 µg/ml for primary stimulations and 1 µg/ml for secondary stimulation, and anti-CD28 (PV1) (from Dr. Carl June, Naval Medical Research Institute, Bethesda, MD) was used at 1 µg/ml. All other staining reagents were purchased from PharMingen.

T Cell Purification and Cultures.
Sorted CD4⁺ DO11.10 T cells (2 x 10⁵/ml) were activated with 0.3 µM OVA peptide (OVA), IL-2, IL-12, and irradiated BALB/c splenocytes as previously described (3). In other experiments, DO11.10 splenocytes (3 x 10⁶/ml) were activated with OVA, IL-2, IL-12 (Th1), or IL-4 (Th2) as indicated in the figure legends. CD8⁺ T cells were sorted from spleen and lymph node cells of 2C mice and activated (2 x 10⁵/ml) using irradiated BALB/c splenocytes (1.5 x 10⁶/ml). CD4⁺ and CD8⁺ T cells were sorted from spleen and lymph node cells of Stat4-deficient or wild-type mice, and stimulated (4 x 10⁵/ml) with irradiated C57BL/6 splenocytes (4 x 10⁶/ml), IL-2, and the indicated cytokines and antibodies.

ELISA and Intracellular Cytokine Staining.
IFN- was measured by ELISA as previously described (3). Intracellular cytokine staining was performed as described elsewhere (18, 23). T cells were stimulated overnight with OVA and either irradiated APCs or plate-bound anti-CD3, and Brefeldin A (10 µg/ml; Epicenter Technologies) was added for the final 4 h. Cells were harvested, washed, and stained for CD4, CD8, and KJ1-26 as indicated in the figure legends. After washing, cells were fixed, washed, permeabilized, and stained for IFN-.

	Results

Top Abstract Materials and Methods Results Discussion References

 
CD4⁺ and CD8⁺ T Cells Have Distinct Requirements for IL-12 and Stat4 in the Production of IFN-.
Previous analyses of Stat4-deficient mice reported five- to sixfold reduced IFN- production based in part on polyclonal cellular activation of unseparated splenocytes (12, 13). To examine the requirement for Stat4 in antigen-specific CD4⁺ T cells, we used DO11.10 TCR-transgenic mice crossed to either wild-type or Stat4-deficient backgrounds. Splenocytes from un-immunized mice were primed in vitro and induced toward Th1 and Th2 phenotypes (4) (Fig. 1 A). As expected, wild-type DO11.10 T cells primed in the presence of IL-12 generated high levels of IFN- upon secondary stimulation. In contrast, Stat4-deficient DO11.10 T cells primed with IL-12 generated nearly 100-fold less IFN-, confirming that Stat4 has a significant role in CD4⁺ T cells for IFN- production.

View larger version (22K): [in this window] [in a new window] [Download PPT slide]   Figure 1 CD4+ T cells exhibit strict requirement for IL-12 and Stat4 in antigen-induced IFN- production. (A) Splenocytes from DO11.10 or DO11.10 x Stat4-deficient (Stat4–/–) were cultured with IL-2 and OVA, and either IL-12 (Th1) or IL-4 (Th2) as indicated for 7 d. Cells were restimulated with irradiated BALB/c splenocytes and OVA for 40 h and supernatants were assayed for IFN-. Data shown are the mean ± SD of four replicate determinations and is representative of three similar experiments. (B) Cells were treated as above except Brefeldin A was added for the final 4 h of a 19-h restimulation. Samples were stained with FITC-conjugated anti-CD4 and biotin-conjugated KJ1-26 followed by cychrome-streptavidin and PE-conjugated anti–IFN- as described in Materials and Methods. Analysis gates were set on live KJ1-26+ cells. Quadrants are based on isotype control staining. (C) Sorted DO11.10 CD4+ T cells were stimulated with OVA/APCs, IL-2, and either IL-12 (black bars) or anti–IL-12 (gray bars). Sorted CD8+ T cells from 2C mice were stimulated with APCs, and either IL-12 (black bars) or anti–IL-12 (gray bars). After 6 d, equal numbers of DO11.10 and 2C T cells were reactivated in the absence of cytokines for 40 h and IFN- was measured. Data are the mean ± SD of IFN- production represented as a percentage of the IL-12–treated condition (% maximum) from four independent experiments.

 
After in vitro priming, clonotype-positive (KJ1-26⁺) T cells from wild type DO11.10 transgenic mice are predominantly CD4⁺. However, in Stat4-deficient mice, as much as 25% of the KJ1-26⁺ T cells are CD4^– (Fig. 1 B) and CD8^– (not shown) after in vitro priming. Double-negative T cells have been reported to exhibit differences in Th1/Th2 regulation, with impaired Th2 development (24, 25). Thus, we wished to assess production of IFN- in CD4⁺ and CD4^– T cells using intracellular cytokine staining (Fig. 1 B). Wild-type DO11.10 T cells produced abundant intracellular IFN- production, whereas Stat4-deficient DO11.10 T cells showed a significantly lower percentage of IFN-–producing cells with lower mean fluorescence intensities relative to wild-type T cells (Fig. 1 B). Of the Stat4-deficient DO11.10 T cells, 6% of CD4⁺ cells produced IFN-, whereas 13% of CD4^– negative cells produced IFN-, implying that in KJ1-26⁺ T cells, CD4⁺ cells are more Stat4 dependent for IFN- production than are CD4^– cells.

These and other results suggest that IFN- production may be regulated differently in various T cell lineages (16, 26, and Carter, L.L., unpublished observations). Therefore, we wished to compare CD4⁺ and CD8⁺ T cells from TCR-transgenic mice for their dependence on IL-12 for driving IFN- production (Fig. 1 C). CD8⁺ or CD4⁺ T cells were sorted from 2C TCR-transgenic mice or DO11.10 mice, respectively, and primed with antigen in the presence of IL-12 or anti–IL-12 antibody for 6 d, restimulated, and assessed for IFN- production. CD4⁺ DO11.10 T cells produced high IFN- when primed with IL-12, but virtually undetectable IFN- when primed with anti–IL-12 antibody (Fig. 1 C). In contrast, 2C CD8⁺ T cells produced high levels of IFN- even when primed in the presence of anti–IL-12 antibody, with IFN- production being reduced only twofold relative to cells primed with IL-12. Thus, CD8⁺ T cells show significant IL-12–independent IFN- production, whereas CD4⁺ T cells do not.

In the mouse, Stat4 is uniquely activated by IL-12 (11, 27, 28). Therefore, IL-12–independent IFN- production by CD8⁺ T cells suggests either that Stat4 activation is IL-12 independent or that IFN- production is Stat4 independent. To distinguish these possibilities, we analyzed purified CD4⁺ and CD8⁺ T cells from Stat4-deficient and wild-type BALB/c mice. T cells were primed in the presence of IL-12 with either allogeneic stimulators or plate-bound anti-CD3 and anti-CD28 (Fig. 2). When primed and reactivated with allogeneic stimulators (Fig. 2, left), Stat4-deficient CD4⁺ T cells produced very little IFN-. In comparison, Stat4-deficient CD8⁺ T cells produced significantly more IFN-, although the level observed was reduced three- to fourfold relative to the wild-type CD8⁺ control. When T cells were reactivated with anti-CD3 (Fig. 2, middle), Stat4-deficient CD4⁺ T cells remained poor IFN- producers, whereas Stat4-deficient CD8⁺ T cells produced IFN- at levels similar to wild-type CD8⁺ controls (Fig. 2, middle). When T cells were primed with anti-CD3/anti-CD28 and IL-12, and reactivated with anti-CD3, Stat4-deficient CD4⁺ T cells again produced very low levels of IFN-, whereas Stat4-deficient CD8⁺ T cells produced high levels of IFN- (Fig. 2, right).

View larger version (20K): [in this window] [in a new window] [Download PPT slide]   Figure 2 CD8+ T cells exhibit Stat4-independent IFN- production. CD4+ (black bars) and CD8+ (gray bars) T cells were sort-purified from pooled lymph nodes and spleens of wild-type or Stat4-deficient (Stat4 –/–) mice and stimulated with IL-2, IL-12, and irradiated allogeneic splenocytes (H-2b) (left and middle) or plate-bound anti-CD3 and anti-CD28 (right). After 6 d, cells were harvested and reactivated at 4 x 105/ml with irradiated allogeneic APCs (left) or plate-bound anti-CD3 (middle and right), and IFN- was measured after 40 h. Data in left and middle panels are the mean ± SD pooled from six independent experiments. Data in right panel are the mean ± SD from one of two experiments.

 
We extended these results with intracellular cytokine staining (Fig. 3). Purified CD4⁺ and CD8⁺ T cells from Stat4-deficient and wild-type mice were primed in the presence of IL-12 using either APCs or anti-CD3/anti-CD28, and reactivated with APCs (Fig. 3 A) or anti-CD3 (Fig. 3 B). CD4⁺ T cells again showed a strict requirement for Stat4 in IFN- production with both forms of activation. In contrast, Stat4-deficient CD8⁺ T cells produced abundant IFN- with either form of activation. With anti-CD3 treatment, equivalent percentages of Stat4-deficient and wild-type CD8⁺ T cells produced IFN-, whereas with activation by APCs, IFN-⁺ Stat4-deficient CD8⁺ T cells were reduced twofold. Thus, in contrast to CD4⁺ T cells, CD8⁺ T cells show significant Stat4-independent IFN- production, which is most apparent with direct TCR-mediated cellular activation.

View larger version (35K): [in this window] [in a new window] [Download PPT slide]   Figure 3 CD4+ and CD8+ T cells have distinct requirements for Stat4 in TCR-induced IFN- production. CD4+ and CD8+ T cells were sorted from lymph nodes and spleens of wild-type or Stat4-deficient mice and stimulated in the presence of IL-2 and IL-12 with either irradiated allogeneic splenocytes (A) or plate-bound anti-CD3 and anti-CD28 (B). After 5 d, cells were restimulated with irradiated allogeneic APCs (A) or plate-bound anti-CD3 (B) for 17 h with Brefeldin A added for the final 5 h. Samples were stained with FITC-conjugated anti-CD4 or anti-CD8, fixed, permeabilized, and stained with PE-conjugated anti–IFN-. Syngeneic splenocytes were used as stimulators for a specificity control and no IFN-+ cells were detected (data not shown). Gates for analysis excluded dead cells and quadrants were set based on isotype control staining. The percentages displayed indicate the frequency of cells positive for IFN- in the CD4+ (top) or CD8+ (bottom) population, rather than the percentage of total cells. Data shown are representative of three independent experiments.

 
Since APCs can produce IL-12 and IL-18 (4, 29, 30), T cell activation using APCs could engage both the TCR and the IL-12/IL-18 pathway for IFN- production. Therefore, we asked if these pathways were differentially Stat4 dependent in CD4⁺ and CD8⁺ T cells (Fig. 4). Purified CD4⁺ and CD8⁺ T cells from Stat4-deficient and wild-type mice were primed with IL-12 and allogeneic APCs and reactivated on day 6 with either anti-CD3 or IL-12/ IL-18. In response to anti-CD3, wild-type CD4⁺, but not Stat4-deficient CD4⁺, T cells produced IFN-. As above, both wild-type and Stat4-deficient CD8⁺ T cells produced IFN-. However, in response to IL-12/IL-18 treatment, both CD4⁺ and CD8⁺ Stat4-deficient T cells failed to produce IFN-. Thus, the IL-12/IL-18 pathway for IFN- production is strictly Stat4 dependent in both CD4⁺ and CD8⁺ T cells. In contrast, the TCR-induced pathway for IFN- production is Stat4 dependent only in CD4⁺, and not CD8⁺, T cells.

View larger version (32K): [in this window] [in a new window] [Download PPT slide]   Figure 4 CD8+ T cells possess both Stat4-independent (TCR) and Stat4-dependent (IL-12/IL-18) pathways for IFN- induction. CD4+ (top) and CD8+ (bottom) T cells were sorted from lymph nodes and spleens of wild-type (black bars) or Stat4-deficient (gray bars) mice and stimulated with irradiated allogeneic splenocytes, IL-2, and IL-12. After 5 d, cells were harvested and equal cell numbers were restimulated by the addition of IL-12 and IL-18 or plate-bound anti-CD3 for 40 h, and IFN- was measured by ELISA. Data are the mean ± SD of four independent experiments.

 

	Discussion

Top Abstract Materials and Methods Results Discussion References

 
Previous observations have suggested the existence of both IL-12–dependent and –independent pathways for IFN- production (12, 13, 16, 31–33). However, since few of these studies analyzed purified cell types, the effects of Stat4 in specific lineages were potentially obscured. Furthermore, recent studies have demonstrated that IFN- gene transcription can be activated by two distinct signaling pathways, one by TCR signaling and other by IL-12 and IL-18 (18), and these pathways were not individually examined in the previous studies. Therefore, the aim of this study was to analyze differences between CD4⁺ and CD8⁺ T cells in their regulation of these two pathways for IFN- production.

In this paper, we make several new observations. First, we show that the IL-12/IL-18 pathway for induction of IFN- operates in CD8⁺ as well as CD4⁺ T cells. Second, we formally demonstrate that the IL-12/IL-18 pathway is strictly Stat4 dependent in both CD4⁺ and CD8⁺ T cells. Third, we have identified an unexpected difference between CD4⁺ and CD8⁺ T cells in TCR signaling. Specifically, CD4⁺ T cells produce IFN- in a completely Stat4-dependent manner, whereas CD8⁺ T cells are Stat4 independent for TCR-induced IFN- production.

Common Regulation in CD4⁺ and CD8⁺ T Cells for IL-12/ IL-18–induced IFN-.
Two pathways are now recognized for IFN- induction (17, 18), one via TCR-signaling and another through IL-12 and IL-18 that acts independently of antigen stimulation (17). The TCR- and IL-12/IL-18– induced pathways were shown to be pharmacologically distinct and to induce different transcription factors (18). In this study, we show that IL-12/IL-18 induction of IFN- operates in CD8⁺ as well as CD4⁺ T cells (Fig. 4). The existence of antigen-independent IFN- production by previously activated T cells from both CD4 and CD8 lineage has significant implications for immune regulation. By stimulating production of cytokines in an antigen-independent manner, this pathway allows antigen-specific T cells to operate like innate immune cells. The Stat4-dependence of the IL-12/ IL-18–induced pathway in both CD4⁺ and CD8⁺ lineages suggest a common IFN- regulatory mechanism.

Distinct Regulation in CD4⁺ and CD8⁺ T Cells for TCR-induced IFN- Production.
In contrast to IL-12/IL-18– induced IFN-, TCR-induced signaling revealed a striking difference in the requirement for Stat4 between CD4⁺ and CD8⁺ T cells. Unseparated Stat4-deficient splenocytes displayed a partial reduction in IFN- production in previous studies (12, 13), whereas pure populations of CD4⁺ T cells show a much more stringent requirement for Stat4 (Fig. 1 A). In contrast, Stat4-deficient CD8⁺ T cells generated abundant IFN- particularly when activated through the TCR. When CD8⁺ T cells were activated using APCs, a partial loss of IFN- production was observed in Stat4-deficient CD8⁺ T cells relative to wild-type controls (Figs. 2, left, and 3 A), suggesting that activation with APCs engages both TCR (Stat4-independent) and IL-12/IL-18 (Stat4-dependent) pathways. Activation of CD8⁺ T cells using anti-CD3 restricts activation to the TCR (Stat4-independent) pathway, resulting in equivalent levels of IFN- production by Stat4-deficient and wild-type CD8⁺ T cells. Distinct regulation of IFN- gene activation between CD4⁺ and CD8⁺ T cells has previously been suggested (26). A Stat4-independent mechanism for IFN- production development has recently been described (34), but as it operated only in the absence of Stat6 and in CD4⁺ T cells, it is distinct from the pathway described here.

Differences in TCR signaling between CD4⁺ and CD8⁺ lineages could reside at several levels. First, CD4⁺ and CD8⁺ T cells may differ in expression of signaling components downstream of the TCR. For example, certain mitogen-activated protein (MAP) kinases implicated in IFN- induction (35, 36) could be differentially expressed or activated in CD4⁺ versus CD8⁺ T cells, being Stat4 dependent only in CD4⁺ T cells. Second, chromatin accessibility of the IFN- gene may differ between primary CD4⁺ and CD8⁺ lineages. In this model, the IFN- gene would be accessible to TCR-induced factors independently of Stat4 in CD8⁺ T cells, but not in CD4⁺ T cells. However, IFN- chromatin structure in CD4⁺ versus CD8⁺ T cells has not yet been compared. Finally, coreceptor signaling could account for the present observations. CD8 may provide a signal that bypasses a Stat4 requirement in IFN- production, or conversely CD4 may provide a signal imposing such a requirement. Indeed, differences between coreceptor association with src family kinase Lck have been reported (37–40), and lack of CD4 expression impairs Th2 responses (24, 25).

In summary, the study presented here makes the first distinction between CD4⁺ and CD8⁺ T cells for the role of Stat4 in regulation of IFN- expression. Given the importance of IFN- in responses to pathogens and in autoimmune processes, it will be important to determine the basis of these lineage-specific differences in the Stat4-requirement for IFN- gene regulation.

	Acknowledgments

This work was supported by National Institutes of Health grants AI34580, AIDK39676, and JDF995012. L.L. Carter is an Associate of the Howard Hughes Medical Institute. K.M. Murphy is an Associate Investigator of the Howard Hughes Medical Institute.

Submitted: 11 December 1998
Revised: 10 February 1999

	References

Top Abstract Materials and Methods Results Discussion References

 

1 Bach EA, Aguet M & Schreiber RD. The IFN gamma receptor: a paradigm for cytokine receptor signaling, Annu Rev Immunol, 1997, 15, 563–591.[Medline]

2 Bancroft GJ, Schreiber RD, Bosma GC, Bosma MJ & Unanue ER. A T cell-independent mechanism of macrophage activation by interferon-gamma, J Immunol, 1987, 139, 1104–1107.[Abstract]

3 Hsieh CS, Heimberger AB, Gold JS, O'Garra A & Murphy KM. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T–cell-receptor transgenic system, Proc Natl Acad Sci USA, 1992, 89, 6065–6069.[Abstract/Free Full Text]

4 Hsieh CS, Macatonia SE, O'Garra A & Murphy KM. Pathogen-induced Th1 phenotype development in CD4+ alpha beta-TCR transgenic T cells is macrophage dependent, Int Immunol, 1993, 5, 371–382.[Abstract/Free Full Text]

5 Seder RA & Paul WE. Acquisition of lymphokine-producing phenotype by CD4+ T cells, Annu Rev Immunol, 1994, 12, 635–673.[Medline]

6 Abbas AK, Murphy KM & Sher A. Functional diversity of T helper lymphocytes, Nature, 1996, 383, 787–793.[Medline]

7 Croft M, Carter L, Swain SL & Dutton RW. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles, J Exp Med, 1994, 180, 1715–1728.[Abstract/Free Full Text]

8 Seder RA, Boulay JL, Finkelman F, Barbier S, Ben-Sasson SZ, Le Gros G & Paul WE. CD8+ T cells can be primed in vitro to produce IL-4, J Immunol, 1992, 148, 1652–1656.[Abstract]

9 Sad S, Marcotte R & Mosmann TR. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines, Immunity, 1995, 2, 271–279.[Medline]

10 Carter LL & Dutton RW. Type 1 and type 2: a fundamental dichotomy for all T-cell subsets, Curr Opin Immunol, 1996, 8, 336–342.[Medline]

11 Jacobson NG, Szabo SJ, Weber-Nordt RM, Zhong Z, Schreiber RD, Darnell JE Jr & Murphy KM. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (STAT)3 and Stat4, J Exp Med, 1995, 181, 1755–1762.[Abstract/Free Full Text]

12 Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, Sangster MY, Vignali DA, Doherty PC, Grosveld GC & Ihle JN. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells, Nature, 1996, 382, 171–174.[Medline]

13 Kaplan MH, Sun YL, Hoey T & Grusby MJ. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice, Nature, 1996, 382, 174–177.[Medline]

14 Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, Chu C, Quelle FW, Nosaka T, Vignali DA et al.. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene, Nature, 1996, 380, 630–633.[Medline]

15 Kaplan MH, Schindler U, Smiley ST & Grusby MJ. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells, Immunity, 1996, 4, 313–319.[Medline]

16 Magram J, Connaughton SE, Warrier RR, Carvajal DM, Wu CY, Ferrante J, Stewart C, Sarmiento U, Faherty DA & Gately MK. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses, Immunity, 1996, 4, 471–481.[Medline]

17 Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, Sana T, Hartley SB, Menon S, Kastelein R, Bazan F & O'Garra A. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB, Immunity, 1997, 7, 571–581.[Medline]

18 Yang J, Murphy TL, Ouyang WJ & Murphy KM. Induction of interferon-gamma production in Th1 CD4+ T cells: evidence for two distinct pathways for promoter activation, Eur J Immunol, 1999, 29, 548–555.[Medline]

19 Ouyang W, Ranganath SH, Weindel K, Bhattacharya D, Murphy TL, Sha WC & Murphy KM. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism, Immunity, 1998, 9, 745–755.[Medline]

20 Sha WC, Nelson CA, Newberry RD, Kranz DM, Russell JH & Loh DY. Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice, Nature, 1988, 335, 271–274.[Medline]

21 Marrack P, Shimonkevitz R, Hannum C, Haskins K & Kappler JW. The major histocompatibility complex– restricted antigen receptor on T cells. IV. An antiidiotypic antibody predicts both antigen and I-specificity, J Exp Med, 1983, 158, 1635–1646.[Abstract/Free Full Text]

22 Tripp CS, Gately MK, Hakimi J, Ling P & Unanue ER. Neutralization of IL-12 decreases resistance to Listeriain SCID and C.B-17 mice. Reversal by IFN-gamma, J Immunol, 1994, 152, 1883–1887.[Abstract]

23 Openshaw P, Murphy EE, Hosken NA, Maino V, Davis K, Murphy K & O'Garra A. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations, J Exp Med, 1995, 182, 1357–1367.[Abstract/Free Full Text]

24 Fowell DJ, Magram J, Turck CW, Killeen N & Locksley RM. Impaired Th2 subset development in the absence of CD4, Immunity, 1997, 6, 559–569.[Medline]

25 Brown DR, Moskowitz NH, Killeen N & Reiner SL. A role for CD4 in peripheral T cell differentiation, J Exp Med, 1997, 186, 101–107.[Abstract/Free Full Text]

26 Aune TM, Penix LA, Rincon MR & Flavell RA. Differential transcription directed by discrete gamma interferon promoter elements in naive and memory (effector) CD4 T cells and CD8 T cells, Mol Cell Biol, 1997, 17, 199–208.[Abstract]

27 Jacobson NG, Szabo SJ, Guler ML, Gorham JD & Murphy KM. Regulation of interleukin-12 signalling during T helper phenotype development, Adv Exp Med Biol, 1996, 409, 61–73.[Medline]

28 Cho SS, Bacon CM, Sudarshan C, Rees RC, Finbloom D, Pine R & O'Shea JJ. Activation of STAT4 by IL-12 and IFN-alpha: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation, J Immunol, 1996, 157, 4781–4789.[Abstract]

29 Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh CS, Culpepper JA, Wysocka M, Trinchieri G, Murphy KM & O'Garra A. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells, J Immunol, 1995, 154, 5071–5079.[Abstract]

30 Yoshimoto T, Okamura H, Tagawa YI, Iwakura Y & Nakanishi K. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells, Proc Natl Acad Sci USA, 1997, 94, 3948–3953.[Abstract/Free Full Text]

31 Piccotti JR, Li K, Chan SY, Ferrante J, Magram J, Eichwald EJ & Bishop DK. Alloantigen-reactive Th1 development in IL-12-deficient mice, J Immunol, 1998, 160, 1132–1138.[Abstract/Free Full Text]

32 Schijns VE, Haagmans BL, Wierda CM, Kruithof B, Heijnen IA, Alber G & Horzinek MC. Mice lacking IL-12 develop polarized Th1 cells during viral infection, J Immunol, 1998, 160, 3958–3964.[Abstract/Free Full Text]

33 de Jong R, Altare F, Haagen IA, Elferink DG, Boer T, van Breda PJ, Vriesman, Kabel PJ, Draaisma JM, van Dissel JT, Kroon FP et al.. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients, Science, 1998, 280, 1435–1438.[Abstract/Free Full Text]

34 Kaplan MH, Wurster AL & Grusby MJ. A signal transducer and activator of transcription (Stat)4-independent pathway for the development of T helper type 1 cells, J Exp Med, 1998, 188, 1191–1196.[Abstract/Free Full Text]

35 Rincon M, Enslen H, Raingeaud J, Recht M, Zapton T, Su MS, Penix LA, Davis RJ & Flavell RA. Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway, EMBO (Eur Mol Biol Organ) J, 1998, 17, 2817–2829.[Medline]

36 Egerton M, Fitzpatrick DR, Catling AD & Kelso A. Differential activation of T cell cytokine production by the extracellular signal-regulated kinase (ERK) signaling pathway, Eur J Immunol, 1996, 26, 2279–2285.[Medline]

37 Ravichandran KS & Burakoff SJ. Evidence for differential intracellular signaling via CD4 and CD8 molecules, J Exp Med, 1994, 179, 727–732.[Abstract/Free Full Text]

38 Itano A, Salmon P, Kioussis D, Tolaini M, Corbella P & Robey E. The cytoplasmic domain of CD4 promotes the development of CD4 lineage T cells, J Exp Med, 1996, 183, 731–741.[Abstract/Free Full Text]

39 Veillette A, Bookman MA, Horak EM & Bolen JB. The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck, Cell, 1988, 55, 301–308.[Medline]

40 Wiest DL, Yuan L, Jefferson J, Benveniste P, Tsokos M, Klausner RD, Glimcher LH, Samelson LE & Singer A. Regulation of T cell receptor expression in immature CD4⁺CD8⁺thymocytes by p56lck tyrosine kinase: basis for differential signaling by CD4 and CD8 in immature thymocytes expressing both coreceptor molecules, J Exp Med, 1993, 178, 1701–1712.[Abstract/Free Full Text]

CiteULike

Complore

Connotea

Del.icio.us

Digg

Facebook

Reddit

Technorati

Twitter

This Article Abstract Full Text (PDF, 135K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Carter, L. L. Articles by Murphy, K. M. Search for Related Content PubMed PubMed Citation Articles by Carter, L. L. Articles by Murphy, K. M. Social Bookmarking                            What's this?